Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™. 2017

Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
Department of Acute Medicine, Oslo University Hospital, Ullevål, Kirkeveien 166, 0407 Oslo, Norway.

Agaricus blazei Murill is an edible mushroom of the Basidiomycetes family, which has been found to contain a number of compounds with antitumor properties, such as proteoglycans and ergosterol. In the present investigation, we show that the commercial mushroom product Andosan, which contains 82.4% Agaricus blazei Murill, together with medicinal mushrooms Hericium erinaceus (14.7%) and Grifola frondosa (2.9%), has a cytotoxic effect on primary myeloma cells, other myeloma cell lines, and leukemia cell lines in vitro. Although the exact content and hence the mechanisms of action of the Andosan extract are unknown, we have found in this investigation indications of cell cycle arrest when myeloma cell lines are cultivated with Andosan. This may be one of the possible explanations for the cytotoxic effects of Andosan.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000363 Agaricales An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms. Agaricaceae,Mushrooms,Agaricale,Mushroom
D000364 Agaricus A basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom (A. campestris) and the commercial mushroom (A. bisporus).
D045424 Complex Mixtures Mixtures of many components in inexact proportions, usually natural, such as PLANT EXTRACTS; VENOMS; and MANURE. These are distinguished from DRUG COMBINATIONS which have only a few components in definite proportions. Complex Extract,Complex Mixture,Crude Extract,Mixtures, Complex,Complex Extracts,Crude Extracts,Extracts, Complex,Extracts, Crude,Extract, Complex,Extract, Crude,Mixture, Complex
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D059447 Cell Cycle Checkpoints Regulatory signaling systems that control the progression through the CELL CYCLE. They ensure that the cell has completed, in the correct order and without mistakes, all the processes required to replicate the GENOME and CYTOPLASM, and divide them equally between two daughter cells. If cells sense they have not completed these processes or that the environment does not have the nutrients and growth hormones in place to proceed, then the cells are restrained (or "arrested") until the processes are completed and growth conditions are suitable. Cell Cycle Arrest,Cell Cycle Control,Cell Cycle Transition Points,Cell Cycle-Transition Points,Arrest, Cell Cycle,Arrests, Cell Cycle,Cell Cycle Arrests,Cell Cycle Checkpoint,Cell Cycle Controls,Cell Cycle-Transition Point,Checkpoint, Cell Cycle,Checkpoints, Cell Cycle,Control, Cell Cycle,Controls, Cell Cycle,Cycle-Transition Point, Cell,Point, Cell Cycle-Transition

Related Publications

Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
May 2007, Contact dermatitis,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
January 2016, PloS one,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
May 2009, Clinical and molecular allergy : CMA,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
December 2016, Scandinavian journal of immunology,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
April 2015, Journal of medicinal food,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
April 2008, Journal of alternative and complementary medicine (New York, N.Y.),
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
March 2010, Cytokine,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
October 2008, Scandinavian journal of immunology,
Jon-Magnus Tangen, and Toril Holien, and Mohammad Reza Mirlashari, and Kristine Misund, and Geir Hetland
July 2002, International immunopharmacology,
Copied contents to your clipboard!